Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs3918242
rs3918242
MMP9
0.010 GeneticVariation BEFREE Vitamin D deficiency was also a predominant feature among all MS patients irrespective of their MMP9 genotypes of rs3918242, implying its association with MS activity in different courses of the disease. 31082619

2019
dbSNP: rs6749704
rs6749704
CCL20
0.010 GeneticVariation BEFREE Frequencies of CT genotype of rs6749704 in CCL20 gene and C allele in MS patients were significantly higher compared to controls. 30399422

2019
dbSNP: rs763780
rs763780
IL17F
0.010 GeneticVariation BEFREE Also significant increase of rs763780 in IL-17F gene was detected in MS patients. 30399422

2019
dbSNP: rs1884444
rs1884444
IL23R ; C1orf141
0.010 GeneticVariation BEFREE Three variants rs2066808, rs2371494, rs11575248 in <i>IL-23A</i> gene and one variant rs1884444 in <i>IL-23R</i> gene were demonstrated to be associated with the risk of MS or other IDD diseases, and the expression level of serum IL-23A in the MS patients was also altered. 27893410

2016
dbSNP: rs2073618
rs2073618
TNFRSF11B ; COLEC10
0.010 GeneticVariation BEFREE The SNP rs2073618 in OPG is associated with an increased risk of MS symptoms and pain with AI therapy, which has not been reported previously. 26798969

2016
dbSNP: rs2228570
rs2228570
VDR
0.010 GeneticVariation BEFREE The aim of this study is to measure plasma levels of OPG and RANKL as well as to analyze VDR FokI polymorphism (rs2228570) in MS patients and healthy individuals to detect any potential correlation. 22805623

2012
dbSNP: rs4950928
rs4950928
CHI3L1
0.010 GeneticVariation BEFREE Allele C of rs4950928 was significantly associated with PPMS patients and with higher plasma CHI3L1 levels. 22183936

2012